Bromperidol has been used in trials studying the treatment of Dementia, Depression, Schizophrenia, Anxiety Disorders, and Psychosomatic Disorders, among others.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Bromperidol. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Bromperidol. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Bromperidol. |
| Hydrocodone | Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Bromperidol. |
| Magnesium sulfate | The therapeutic efficacy of Bromperidol can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Bromperidol may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Bromperidol. |
| Mirtazapine | Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Bromperidol. |
| Orphenadrine | Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Bromperidol. |
| Pramipexole | Bromperidol may increase the sedative activities of Pramipexole. |
| Ropinirole | Bromperidol may increase the sedative activities of Ropinirole. |
| Rotigotine | Bromperidol may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Bromperidol. |
| Sodium oxybate | Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Bromperidol. |
| Thalidomide | Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Amisulpride | Bromperidol may increase the antipsychotic activities of Amisulpride. |
| Methylphenidate | The risk or severity of adverse effects can be increased when Bromperidol is combined with Methylphenidate. |
| Dexmethylphenidate | The risk or severity of adverse effects can be increased when Bromperidol is combined with Dexmethylphenidate. |
| Metoclopramide | The risk or severity of adverse effects can be increased when Metoclopramide is combined with Bromperidol. |
| Quinagolide | The therapeutic efficacy of Quinagolide can be decreased when used in combination with Bromperidol. |
| Sulpiride | Bromperidol may increase the antipsychotic activities of Sulpiride. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Bromperidol. |
| Lithium citrate | Lithium citrate may increase the neurotoxic activities of Bromperidol. |
| Lithium hydroxide | Lithium hydroxide may increase the neurotoxic activities of Bromperidol. |
| Mequitazine | Bromperidol may increase the arrhythmogenic activities of Mequitazine. |
| Tetrabenazine | The risk or severity of adverse effects can be increased when Bromperidol is combined with Tetrabenazine. |
| Deutetrabenazine | The risk or severity of adverse effects can be increased when Bromperidol is combined with Deutetrabenazine. |
| Ethanol | Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Bromperidol. |
| Zimelidine | The risk or severity of adverse effects can be increased when Bromperidol is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Bromperidol is combined with Dapoxetine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Bromperidol is combined with Seproxetine. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Bromperidol is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Bromperidol is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Bromperidol is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Bromperidol is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Bromperidol is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Bromperidol is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Bromperidol is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Bromperidol is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Bromperidol is combined with Escitalopram. |
| Milnacipran | The risk or severity of adverse effects can be increased when Bromperidol is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Bromperidol is combined with Desvenlafaxine. |
| Levomilnacipran | The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Bromperidol. |
| Indalpine | The risk or severity of adverse effects can be increased when Bromperidol is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Bromperidol is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Bromperidol is combined with Alaproclate. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Bromperidol. |
| Propiomazine | The risk or severity of CNS depression can be increased when Propiomazine is combined with Bromperidol. |
| Scopolamine | The risk or severity of CNS depression can be increased when Scopolamine is combined with Bromperidol. |
| Zopiclone | The risk or severity of adverse effects can be increased when Bromperidol is combined with Zopiclone. |
| Cabergoline | The risk or severity of adverse effects can be increased when Cabergoline is combined with Bromperidol. |
| Zolmitriptan | The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Bromperidol. |
| Dextromethorphan | The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Bromperidol. |
| Mazindol | The risk or severity of adverse effects can be increased when Mazindol is combined with Bromperidol. |
| Linezolid | The risk or severity of adverse effects can be increased when Linezolid is combined with Bromperidol. |
| Almotriptan | The risk or severity of adverse effects can be increased when Almotriptan is combined with Bromperidol. |
| Naratriptan | The risk or severity of adverse effects can be increased when Naratriptan is combined with Bromperidol. |
| Rizatriptan | The risk or severity of adverse effects can be increased when Rizatriptan is combined with Bromperidol. |
| Frovatriptan | The risk or severity of adverse effects can be increased when Frovatriptan is combined with Bromperidol. |
| Ergoloid mesylate | The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Bromperidol. |
| Chlorpheniramine | The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Bromperidol. |
| Procarbazine | The risk or severity of adverse effects can be increased when Procarbazine is combined with Bromperidol. |
| Bromocriptine | The risk or severity of adverse effects can be increased when Bromocriptine is combined with Bromperidol. |
| Rasagiline | The risk or severity of adverse effects can be increased when Rasagiline is combined with Bromperidol. |
| Lorcaserin | The risk or severity of adverse effects can be increased when Lorcaserin is combined with Bromperidol. |
| Etoperidone | The risk or severity of adverse effects can be increased when Etoperidone is combined with Bromperidol. |
| Lorpiprazole | The risk or severity of adverse effects can be increased when Lorpiprazole is combined with Bromperidol. |
| Amphetamine | Bromperidol may decrease the stimulatory activities of Amphetamine. |
| Phentermine | Bromperidol may decrease the stimulatory activities of Phentermine. |
| Pseudoephedrine | Bromperidol may decrease the stimulatory activities of Pseudoephedrine. |
| Benzphetamine | Bromperidol may decrease the stimulatory activities of Benzphetamine. |
| Diethylpropion | Bromperidol may decrease the stimulatory activities of Diethylpropion. |
| Lisdexamfetamine | Bromperidol may decrease the stimulatory activities of Lisdexamfetamine. |
| Mephentermine | Bromperidol may decrease the stimulatory activities of Mephentermine. |
| MMDA | Bromperidol may decrease the stimulatory activities of MMDA. |
| 2,5-Dimethoxy-4-ethylamphetamine | Bromperidol may decrease the stimulatory activities of 2,5-Dimethoxy-4-ethylamphetamine. |
| Chlorphentermine | Bromperidol may decrease the stimulatory activities of Chlorphentermine. |
| Methylenedioxyethamphetamine | Bromperidol may decrease the stimulatory activities of Methylenedioxyethamphetamine. |
| Dextroamphetamine | Bromperidol may decrease the stimulatory activities of Dextroamphetamine. |
| Metamfetamine | Bromperidol may decrease the stimulatory activities of Metamfetamine. |
| Iofetamine I-123 | Bromperidol may decrease the stimulatory activities of Iofetamine I-123. |
| Ritobegron | Bromperidol may decrease the stimulatory activities of Ritobegron. |
| Mephedrone | Bromperidol may decrease the stimulatory activities of Mephedrone. |
| Methoxyphenamine | Bromperidol may decrease the stimulatory activities of Methoxyphenamine. |
| Gepefrine | Bromperidol may decrease the stimulatory activities of Gepefrine. |
| 2,5-Dimethoxy-4-ethylthioamphetamine | Bromperidol may decrease the stimulatory activities of 2,5-Dimethoxy-4-ethylthioamphetamine. |
| Phendimetrazine | Bromperidol may decrease the stimulatory activities of Phendimetrazine. |
| Botulinum toxin type B | The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Bromperidol. |
| Botulinum toxin type A | The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Bromperidol. |